PMX 205
Tocris Bioscience, part of Bio-Techne | Catalog # 5196
Potent C5a receptor peptide antagonist
Key Product Details
Description
Potent C5a receptor peptide antagonist
Product Description
PMX 205 is a potent C5a receptor peptide antagonist (IC50 = 31 nM). Ameliorates experimentally-induced colon inflammation in mice. Reduces fibrillar amyloid deposits, decreases hyperphosphorylated tau levels and rescues cognitive function in a mouse model of Alzheimer's disease. Also improves hindlimb grip strength and slows disease progression in the hSOD1G93A mouse model of amyotrophic lateral sclerosis. Orally active and brain penetrant.Product Specifications
Molecular Weight
839.05
Formula
C45H62N10O6
Storage
Store at -20°C
Purity
≥95% (HPLC)
CAS Number
514814-49-4
PubChem ID
90489023
InChI Key
YUIBSMOWXFHTBD-UHFFFAOYSA-N
SMILES
NC(=N)NCCCC1NC(=O)C(CC2C=NC3=CC=CC=C23)NC(=O)C(CC2CCCCC2)NC(=O)C2CCCN2C(=O)C(CCCNC1=O)NC(=O)CCC1=CC=CC=C1
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solubility | Soluble to 1mg/ml in water with sonication |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Kumar Development and validation of a LC-MS/MS assay for pharmacokinetic studies of complement C5a receptor antagonists PMX53 and PMX205 in mice. Sci.Rep. 2018 PMID: 29802264
- Lee Pharmacological inhibition of complement C5a-C5a1 receptor signalling ameliorates disease pathology in the hSOD1G93A mouse model of amyotrophic lateral sclerosis. Br.J.Pharmacol. 2017 PMID: 28128456
- Fonseca Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease. J.Immunol. 2009 PMID: 19561098
- Jain The C5a receptor antagonist PMX205 ameliorates experimentally induced colitis associated with increased IL-4 and IL-10. Br.J.Pharmacol. 2013 PMID: 22924972
- March Potent cyclic antagonists of the complement C5a receptor on human polymorphonuclear leukocytes. Relationships between structures and activity. Mol.Pharmacol. 2004 PMID: 15044616
Product Specific Notices for PMX 205
For research use only
Loading...
Loading...